micro-community-banner
 
  • Saved

10mo
Virtual horizons: Enhancing rehabilitation of neuromuscular diseases through virtual reality and gamification - PubMed

Virtual horizons: Enhancing rehabilitation of neuromuscular diseases through virtual reality and gamification - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39973447/

This systematic review identified that VR and gamification provide the potential to enhance rehabilitation outcomes in patients suffering from NMDs. The future will doubtless have more subjects included and optimization...

Virtual reality and gamified rehabilitation enhance motor function, motivation, and well-being in neuromuscular disease patients, improving engagement and delaying decline. Emerging technologies offer promising advancements for personalized, effective rehabilitation practices.

  • Saved

10mo
Potential diagnostic tools for intensive care unit acquired weakness: A systematic review - PubMed

Potential diagnostic tools for intensive care unit acquired weakness: A systematic review - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39995749/

PROSPERO Registration Number CRD42024573139.

This study reviews diagnostic tools for ICU-acquired weakness, highlighting their strengths and limitations. No single definitive tool exists, necessitating a multimodal approach. Future research should refine and validate diagnostic methods.

  • Saved

10mo
American Academy of Neurology Annual Meeting

The American Academy of Neurology (AAN) is hosting its annual meeting in San Diego and online from April 5 to 9, 2025.

Neurologists and neuroscience professionals will gather for the meeting, which boasts more than 190 education and scientific programs.

We will be covering the event for you, so check your email for news reports with highlights and a wrap-up of the conference. Click above to view some of the highlights that caught our attention.

  • Saved

10mo
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Neonatal Fc Receptor Inhibitor Rozanolixizumab: An Ethnic Sensitivity Study in Healthy Japanese, Chinese, and White Participants - PubMed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Neonatal Fc Receptor Inhibitor Rozanolixizumab: An Ethnic Sensitivity Study in Healthy Japanese, Chinese, and White Participants - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39569616/

Rozanolixizumab is an anti-human neonatal Fc receptor humanized immunoglobulin (Ig) G4 monoclonal antibody that reduces IgG, including pathogenic IgG autoantibodies. Rozanolixizumab safety and tolerability have been assessed in previous clinical...

Rozanolixizumab showed similar safety, tolerability, and IgG-lowering effects across Japanese, Chinese, and White participants, despite lower exposure in Asian groups due to lower body weight, supporting cross-ethnicity data applicability.

  • Saved

10mo
New and Emerging Biological Therapies for Myasthenia Gravis: A Focussed Review for Clinical Decision-Making - PubMed

New and Emerging Biological Therapies for Myasthenia Gravis: A Focussed Review for Clinical Decision-Making - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39869260/

Myasthenia gravis (MG) is a rare autoimmune disease characterised by exertion-induced muscle weakness that can lead to potentially life-threatening myasthenic crises. Detectable antibodies are directed against specific postsynaptic structures of...

Myasthenia gravis is a chronic autoimmune disease marked by muscle weakness. Recent targeted therapies, including complement and FcRn inhibitors, are transforming treatment and improving patient outcomes beyond traditional methods.